Journal article
Patient- and Community-Level Characteristics Associated With Respiratory Syncytial Virus Vaccination
JAMA network open, Vol.8(4), e252841
04/01/2025
DOI: 10.1001/jamanetworkopen.2025.2841
PMCID: PMC11962666
PMID: 40168024
Abstract
In 2023, the first respiratory syncytial virus (RSV) vaccines were recommended for US adults 60 years or older, but few data are available about which patients were most likely to receive vaccine to inform future RSV vaccine outreach efforts.
To assess patient- and community-level characteristics associated with RSV vaccine receipt and patient knowledge and attitudes related to RSV disease and RSV vaccines.
During the first season of RSV vaccine use from October 1, 2023, to April 30, 2024, adults 60 years or older hospitalized with RSV-negative acute respiratory illness were enrolled in this cross-sectional study from 26 hospitals in 20 US states. Sociodemographic and clinical data were abstracted from health records, and structured interviews were conducted for knowledge and attitudes about RSV disease and RSV vaccines.
Age, sex, race and ethnicity, pulmonary disease, immunocompromised status, long-term care facility residence, medical insurance, social vulnerability index (SVI), and educational level.
The exposures were identified a priori as possible factors associated with RSV vaccine receipt and were entered into a modified Poisson regression model accounting for state clustering, to assess for association with RSV vaccine receipt. Knowledge and attitudes were summarized with frequencies and proportions.
Among 6746 hospitalized adults 60 years or older, median age was 73 (IQR, 66-80) years and 3451 (51.2%) were female. Among the 6599 patients with self-reported race and ethnicity, 699 (10.6%) were Hispanic, 1288 (19.5%) were non-Hispanic Black, 4299 (65.1%) were non-Hispanic White, and 313 (4.7%) were other race or ethnicity. There were 700 RSV-vaccinated (10.4%) and 6046 unvaccinated (89.6%) adults. Among 3219 unvaccinated adults who responded to RSV knowledge questions, 1519 (47.2%) had not heard of RSV or were unsure; 2525 of 3218 (78.5%) were unsure if they were eligible for RSV vaccine or thought they were not. In adjusted analyses, characteristics associated with RSV vaccination were being 75 years or older (adjusted risk ratio [ARR], 1.23; 95% CI, 1.10-1.38, P < .001), being male (ARR, 1.15; 95% CI, 1.01-1.30; P = .04), and having pulmonary disease (ARR, 1.39; 95% CI, 1.16-1.67; P < .001), immunocompromised status (ARR, 1.30; 95% CI, 1.14-1.48; P < .001), low (ARR, 1.47; 95% CI, 1.18-1.83, P < .001) or moderate (ARR, 1.47; 95% CI, 1.21-1.79; P < .001) SVI, and educational level consisting of 4 or more years of college (ARR, 2.91; 95% CI, 2.14-3.96; P < .001), at least some college or technical training (ARR, 1.85; 95% CI, 1.35-2.53; P < .001), or grade 12 education or General Educational Development (ARR, 1.44; 95% CI, 1.03-2.00; P = .03). RSV vaccination was less likely among residents of long-term care facilities, patients with Medicaid coverage, and uninsured patients.
In this cross-sectional study of hospitalized adults, knowledge of RSV disease and RSV vaccine eligibility was low. Older adults and those with certain medical conditions were more likely to have received vaccine, suggesting appropriate prioritization, but sociodemographic differences in vaccine uptake occurred.
Details
- Title: Subtitle
- Patient- and Community-Level Characteristics Associated With Respiratory Syncytial Virus Vaccination
- Creators
- Diya Surie - National Center for Immunization and Respiratory DiseasesKatharine A Yuengling - National Center for Immunization and Respiratory DiseasesBasmah Safdar - Yale UniversityAdit A Ginde - University of Colorado Anschutz Medical CampusIthan D Peltan - University of UtahSamuel M Brown - University of UtahManjusha Gaglani - Baylor College of MedicineShekhar Ghamande - Baylor College of MedicineRobert L Gottlieb - Texas Christian UniversityCristie Columbus - University of DallasNicholas M Mohr - University of IowaKevin W Gibbs - Wake Forest UniversityDavid N Hager - Johns Hopkins University School of MedicineMary O'Rourke - Hennepin County Medical CenterMichelle N Gong - Albert Einstein College of MedicineAmira Mohamed - Albert Einstein College of MedicineNicholas J Johnson - University of WashingtonJay S Steingrub - Baystate Medical CenterAkram Khan - University of PortlandAbhijit Duggal - Cleveland ClinicJennifer G Wilson - Stanford UniversityNida Qadir - University of California, Los AngelesSteven Y Chang - University of California, Los AngelesChristopher Mallow - University of MiamiLaurence W Busse - Emory UniversityJamie Felzer - Emory UniversityJennie H Kwon - Washington University in St. LouisMatthew C Exline - The Ohio State UniversityIvana A Vaughn - Ford Motor Company (United States)Mayur Ramesh - Ford Motor Company (United States)Adam S Lauring - University of MichiganEmily T Martin - University of MichiganJarrod M Mosier - University of ArizonaEstelle S Harris - University of UtahAdrienne Baughman - Vanderbilt University Medical CenterSydney A Swan - Vanderbilt University Medical CenterCassandra A Johnson - Vanderbilt University Medical CenterPaul W Blair - Vanderbilt University Medical CenterNathaniel M Lewis - National Center for Immunization and Respiratory DiseasesSascha Ellington - National Center for Immunization and Respiratory DiseasesRachel E Rutkowski - National Center for Immunization and Respiratory DiseasesYuwei Zhu - Vanderbilt University Medical CenterWesley H Self - Vanderbilt University Medical CenterFatimah S Dawood - National Center for Immunization and Respiratory DiseasesInvestigating Respiratory Viruses in the Acutely Ill (IVY) Network
- Resource Type
- Journal article
- Publication Details
- JAMA network open, Vol.8(4), e252841
- DOI
- 10.1001/jamanetworkopen.2025.2841
- PMID
- 40168024
- PMCID
- PMC11962666
- NLM abbreviation
- JAMA Netw Open
- ISSN
- 2574-3805
- eISSN
- 2574-3805
- Publisher
- AMER MEDICAL ASSOC; CHICAGO
- Grant note
- CDC: 75D30122C14944
This work was supported by contract 75D30122C14944 to Vanderbilt University Medical Center by the CDC.
- Language
- English
- Date published
- 04/01/2025
- Academic Unit
- Epidemiology; Emergency Medicine; Anesthesia; Injury Prevention Research Center
- Record Identifier
- 9984804805002771
Metrics
5 Record Views